60.1K
Verified Solution
Link Copied!
Ellis Pharmaceuticals, LLC cash flow statements are as follows:
| Description | 2019 | 2018 | 2017 | 2016 |
| Beginning Cash | 511 | 452 | 103 | 100 |
| Cash from Operating | -58 | -115 | -205 | -415 |
| Cash from Investing | -179 | 105 | 116 | 203 |
| Cash from Financing | -216 | 69 | 438 | 215 |
| Net Change in Cash | -453 | 59 | 349 | 3 |
| Ending Cash | 58 | 511 | 452 | 103 |
Choose one assertion we cannot make from this data:
| | A. | The cash drain has ended. |
| | B. | Ellis has been selling assets until 2019. |
| | C. | Ellis either borrowed money or sold equity in 2017. |
| | D. | Ellis most likely repaid debt in 2019. |
Answer & Explanation
Solved by verified expert
